+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cushings Syndrome and Acromegaly Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 181 Pages
  • June 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5978975

The global Cushing s Syndrome and Acromegaly treatment market is on the verge of significant growth, driven by advancements in medical technology and increasing healthcare expenditure. Cushing s Syndrome and Acromegaly, both serious endocrine disorders, have been gaining attention due to their debilitating symptoms and the rising prevalence of these conditions. This report provides an overview of the market dynamics, key drivers, and regional insights, shedding light on the factors propelling the growth of this market.



Understanding Cushing s Syndrome and Acromegaly

Cushing's Syndrome is characterized by symptoms such as high blood pressure, abdominal obesity, a round red face, a fatty lump between the shoulders, weak muscles and bones, acne, and fragile skin. Most cases are caused by pituitary adenoma and multiple endocrine neoplasia.

Acromegaly, on the other hand, involves symptoms such as enlargement of the hands, feet, forehead, jaw, and nose, resulting in joint pain, thickening of the skin, deepening of the voice, headaches, and vision problems. Other complications include type 2 diabetes and hypertension. Acromegaly is mainly caused by the pituitary gland producing excessive growth hormone, usually due to a benign tumor known as a pituitary adenoma.



Market Segmentation

The Cushing s Syndrome and Acromegaly treatment market by drug type is segmented into Cushing s Syndrome treatment and Acromegaly treatment. The Cushing s Syndrome treatment is further sub-segmented into Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, and other Off-label drugs. Acromegaly treatment is divided into Somatostatin, Glucocorticoid Receptor Inhibitors, and other Off-label drugs.

Based on the distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.



Regional Insights

North America is expected to dominate the global Cushing s Syndrome and Acromegaly treatment market, driven by rapid technological advancements and substantial purchasing power. The presence of key players such as Novartis AG and Pfizer Inc., coupled with excellent reimbursement policies, further supports market growth.

Europe is the second dominant market, with Germany leading due to its advanced medical industry and large players like HRA Pharma. Other significant markets in Europe include France, the U.K., and Spain.

Asia Pacific is poised for significant growth, led by Japan, Australia, and China. The consolidation of large healthcare providers and increased healthcare insurance penetration are key factors driving the market in this region. India is also expected to contribute substantially to the market growth.



Market Drivers


Several factors are driving the growth of the Cushing s Syndrome and Acromegaly treatment market:

  • Technological Advancements: The development of targeted drug therapy with minimal side effects is expected to drive the adoption of treatment products for these conditions.
  • Government Support: Support for orphan diseases and advancements in imaging technologies are anticipated to boost market growth.
  • Demographic Factors: The aging population and increasing healthcare expenditure globally are significant drivers of market growth.
  • High Relapse Rates: The high relapse rates for Cushing s Syndrome and Acromegaly after surgery necessitate ongoing treatment, further driving market demand.

Key Players and Market Dynamics

The U.S. leads the market in North America due to faster uptake of technology and substantial healthcare expenditure, which was almost 16% of its GDP in 2017. Europe follows, with Germany being a key market due to its large medical industry and advanced players. The Asia Pacific market is dominated by Japan, Australia, and China, with China expected to witness rapid growth.



Key Market Segmentation:


By Types

  • Cushing s Syndrome Treatment
  • Glucocorticoid Receptor Inhibitors
  • Somatostatin
  • Ketoconazole HRA
  • Other Off-label
  • Acromegaly Treatment
  • Somatostatin
  • Glucocorticoid Receptor Inhibitors
  • Other Off-label

By Distribution channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Western Europe
  • Latin America
  • Asia Pacific
  • Rest of World


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Cushings Syndrome and Acromegaly Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.6.1. World Economic Projections
2.7. PESTLE Analysis
3. Global Cushings Syndrome and Acromegaly Treatment Market Outlook, 2018 - 2031
3.1. Global Cushings Syndrome and Acromegaly Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Cushing’s Syndrome Treatment
3.1.1.1.1. Glucocorticoid Receptor Inhibitors
3.1.1.1.2. Somatostatin
3.1.1.1.3. Ketoconazole HRA
3.1.1.1.4. Other Off label
3.1.1.2. Acromegaly Treatment
3.1.1.2.1. Somatostatin
3.1.1.2.2. Glucocorticoid Receptor Inhibitors
3.1.1.2.3. Other Off label
3.2. Global Cushings Syndrome and Acromegaly Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospital Pharmacies
3.2.1.2. Retail Pharmacies
3.2.1.3. Online Pharmacies
3.3. Global Cushings Syndrome and Acromegaly Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Cushings Syndrome and Acromegaly Treatment Market Outlook, 2018 - 2031
4.1. North America Cushings Syndrome and Acromegaly Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Cushing’s Syndrome Treatment
4.1.1.1.1. Glucocorticoid Receptor Inhibitors
4.1.1.1.2. Somatostatin
4.1.1.1.3. Ketoconazole HRA
4.1.1.1.4. Other Off label
4.1.1.2. Acromegaly Treatment
4.1.1.2.1. Somatostatin
4.1.1.2.2. Glucocorticoid Receptor Inhibitors
4.1.1.2.3. Other Off label
4.2. North America Cushings Syndrome and Acromegaly Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospital Pharmacies
4.2.1.2. Retail Pharmacies
4.2.1.3. Online Pharmacies
4.3. North America Cushings Syndrome and Acromegaly Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Cushings Syndrome and Acromegaly Treatment Market Outlook, 2018 - 2031
5.1. Europe Cushings Syndrome and Acromegaly Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Cushing’s Syndrome Treatment
5.1.1.1.1. Glucocorticoid Receptor Inhibitors
5.1.1.1.2. Somatostatin
5.1.1.1.3. Ketoconazole HRA
5.1.1.1.4. Other Off label
5.1.1.2. Acromegaly Treatment
5.1.1.2.1. Somatostatin
5.1.1.2.2. Glucocorticoid Receptor Inhibitors
5.1.1.2.3. Other Off label
5.2. Europe Cushings Syndrome and Acromegaly Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospital Pharmacies
5.2.1.2. Retail Pharmacies
5.2.1.3. Online Pharmacies
5.3. Europe Cushings Syndrome and Acromegaly Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cushings Syndrome and Acromegaly Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Cushings Syndrome and Acromegaly Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Cushing’s Syndrome Treatment
6.1.1.1.1. Glucocorticoid Receptor Inhibitors
6.1.1.1.2. Somatostatin
6.1.1.1.3. Ketoconazole HRA
6.1.1.1.4. Other Off label
6.1.1.2. Acromegaly Treatment
6.1.1.2.1. Somatostatin
6.1.1.2.2. Glucocorticoid Receptor Inhibitors
6.1.1.2.3. Other Off label
6.2. Asia Pacific Cushings Syndrome and Acromegaly Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospital Pharmacies
6.2.1.2. Retail Pharmacies
6.2.1.3. Online Pharmacies
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Cushings Syndrome and Acromegaly Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Cushings Syndrome and Acromegaly Treatment Market Outlook, 2018 - 2031
7.1. Latin America Cushings Syndrome and Acromegaly Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Cushing’s Syndrome Treatment
7.1.1.1.1. Glucocorticoid Receptor Inhibitors
7.1.1.1.2. Somatostatin
7.1.1.1.3. Ketoconazole HRA
7.1.1.1.4. Other Off label
7.1.1.2. Acromegaly Treatment
7.1.1.2.1. Somatostatin
7.1.1.2.2. Glucocorticoid Receptor Inhibitors
7.1.1.2.3. Other Off label
7.2. Latin America Cushings Syndrome and Acromegaly Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hospital Pharmacies
7.2.1.2. Retail Pharmacies
7.2.1.3. Online Pharmacies
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Cushings Syndrome and Acromegaly Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Cushings Syndrome and Acromegaly Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Cushings Syndrome and Acromegaly Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Cushing’s Syndrome Treatment
8.1.1.1.1. Glucocorticoid Receptor Inhibitors
8.1.1.1.2. Somatostatin
8.1.1.1.3. Ketoconazole HRA
8.1.1.1.4. Other Off label
8.1.1.2. Acromegaly Treatment
8.1.1.2.1. Somatostatin
8.1.1.2.2. Glucocorticoid Receptor Inhibitors
8.1.1.2.3. Other Off label
8.2. Middle East & Africa Cushings Syndrome and Acromegaly Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospital Pharmacies
8.2.1.2. Retail Pharmacies
8.2.1.3. Online Pharmacies
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Cushings Syndrome and Acromegaly Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Cushings Syndrome and Acromegaly Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Cushings Syndrome and Acromegaly Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Novartis AG
9.3.1.1. Company Overview
9.3.1.2. Therapy Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Corcept Therapeutics
9.3.2.1. Company Overview
9.3.2.2. Therapy Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. HRA Pharma
9.3.3.1. Company Overview
9.3.3.2. Therapy Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Bristol-Myers Squibb Company
9.3.4.1. Company Overview
9.3.4.2. Therapy Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Pfizer Inc.
9.3.5.1. Company Overview
9.3.5.2. Therapy Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Ipsen Biopharmaceuticals, Inc.
9.3.6.1. Company Overview
9.3.6.2. Therapy Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Others
9.3.7.1. Company Overview
9.3.7.2. Therapy Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis AG
  • Corcept Therapeutics
  • HRA Pharma
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.

Methodology

Loading
LOADING...